Gene · 54567
Papers4,267
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 4,267
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Characterization of prevalent tyrosine kinase inhibitors and their challenges in glioblastoma treatment. | Front Chem | 2023 | 38264122 | PubTator, text mining | PubMed |
| Single-cell sequencing reveals an important role of SPP1 and microglial activation in age-related macular degeneration. | Front Cell Neurosci | 2023 | 38259505 | PubTator, text mining | PubMed |
| The Regulation of Exosome Generation and Function in Physiological and Pathological Processes. | Int J Mol Sci | 2023 | 38203424 | PubTator, text mining | PubMed |
| Progress in Glioma Stem Cell Research. | Cancers (Basel) | 2023 | 38201528 | PubTator, text mining | PubMed |
| Circular RNAs in inflammatory bowel disease. | Front Immunol | 2023 | 38187401 | PubTator, text mining | PubMed |
| The categorizations of vasculogenic mimicry in clear cell renal cell carcinoma unveil inherent connections with clinical and immune features. | Front Pharmacol | 2023 | 38178861 | PubTator, text mining | PubMed |
| Hepatitis B Virus-Encoded MicroRNA (HBV-miR-3) Inhibits FIH-1 Expression to Promote Tumor Angiogenesis in HBV-Related Hepatocellular Carcinoma. | J Hepatocell Carcinoma | 2023 | 38163053 | PubTator, text mining | PubMed |
| Type I Interferons induce endothelial destabilization in Systemic Lupus Erythematosus in a Tie2-dependent manner. | Front Immunol | 2023 | 38162654 | PubTator, text mining | PubMed |
| Lineage tracing of T cell differentiation from T-iPSC by 2D feeder-free culture and 3D organoid culture. | Front Immunol | 2023 | 38162650 | PubTator, text mining | PubMed |
| Ribosomal protein L8 regulates the expression and splicing pattern of genes associated with cancer-related pathways. | Turk J Biol | 2023 | 38155938 | PubTator, text mining | PubMed |
| Study on Potential Differentially Expressed Genes in Idiopathic Pulmonary Fibrosis by Bioinformatics and Next-Generation Sequencing Data Analysis. | Biomedicines | 2023 | 38137330 | PubTator, text mining | PubMed |
| The role and application of vesicles in triple-negative breast cancer: Opportunities and challenges. | Mol Ther Oncolytics | 2023 | 38130701 | PubTator, text mining | PubMed |
| Chromatin accessibility analysis suggested vascular induction of the biliary epithelium via the Notch signaling pathway in the human liver. | BMC Res Notes | 2023 | 38129911 | PubTator, text mining | PubMed |
| Macrophage polarization in spinal cord injury repair and the possible role of microRNAs: A review. | Heliyon | 2023 | 38125535 | PubTator, text mining | PubMed |
| Evaluation of variable new antigen receptors (vNARs) as a novel cathepsin S (CTSS) targeting strategy. | Front Pharmacol | 2023 | 38116078 | PubTator, text mining | PubMed |
| Mulibrey nanism and immunological complications: a comprehensive case report and literature review. | Front Immunol | 2023 | 38116000 | PubTator, text mining | PubMed |
| AML alters bone marrow stromal cell osteogenic commitment via Notch signaling. | Front Immunol | 2023 | 38111584 | PubTator, text mining | PubMed |
| Bispecific antibodies revolutionizing breast cancer treatment: a comprehensive overview. | Front Immunol | 2023 | 38111570 | PubTator, text mining | PubMed |
| The benign nature and rare occurrence of cardiac myxoma as a possible consequence of the limited cardiac proliferative/ regenerative potential: a systematic review. | BMC Cancer | 2023 | 38110859 | PubTator, text mining | PubMed |
| Revolutionizing cancer immunotherapy: unleashing the potential of bispecific antibodies for targeted treatment. | Front Immunol | 2023 | 38106416 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/54567/papers?page=14